Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy candidate AT-108 to clinical trial stage
June 11, 2024
June 11, 2024
May 25, 2023
April 20, 2023
December 6, 2022
September 6, 2022
August 4, 2022
May 24, 2022
May 3, 2022
February 2, 2022
July 22, 2026
Milestone marks the transition of Low Dose IL-2 from clinical development to a scalable, regulatory-ready commercial manufacturing process Strategic s...
July 20, 2026
New registration expands access to minimally invasive skin microbiopsy for clinical, research, and wellness applications. Trajan today announced the H...
July 15, 2026
Consortium initially brings together Lunit, Mindpeak, Imagene AI, Dipath AI, Nucleai, Tivenix and Indica Labs to give biopharma sponsors a single CRO-...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225